Actual Medicinal Product (AMP) Reltebon 10mg modified-release tablets (CST Pharma Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from light. Protect from moisture. No stability data in MCAs available.
- Provenance
-
This recommendation is based on the products Longtec 10mg prolonged-release tablets (Qdem Pharmaceuticals Limited) and Ixyldone 10mg prolonged-release tablets (Morningside Healthcare Ltd).
- Generic
- Oxycodone
- Formulation
- Oxycodone 10mg modified-release tablets
-
Oxycodone
-
Oxycodone 10mg modified-release tablets
-
Reltebon 10mg modified-release tablets (CST Pharma Ltd)
-
-
Oxycodone 10mg tablets